Drug Discovery Research

May 9, 2013 - HNF-WVU-NIOSH Study update:: We are pleased to update our readers on the progress of the WVU-NIOSH study, “A Bi-Directional Translational Model of Exercise Training in the Treatment of Charcot-Marie-Tooth Disease”, funded by HNF. Read More...
Apr 1, 2013 - Assay Depot And Rare Genomics Institute Award Prizes To Study 26 Rare Diseases : Assay Depot And Rare Genomics Institute Award Prizes To Study 26 Rare Diseases More Than $500,000 Worth of Services, Reagents, and Prize Money SAN DIEGO and ST. LOUIS, Feb. 28, 2013 /PRNewsw Read More...
Feb 27, 2013 - "Fighter Mom's" Join Forces: Is it just coincidence, being in the right place at the right time, or is it synchronicity? Synchronicity, as defined by Wikipedia: "The idea of synchronicity is that the conceptual relationship of m Read More...
Jan 9, 2013 - Dr. Robert Baloh Answers Our Questions About iPS Cell Research: Big news is happening on a cellular level at Cedars-Sinai Medical Center’s Regenerative Medicine Institute in Los Angeles, CA. Robert H. Baloh, MD PhD, Director of Neuromuscular Medicine, in conjunct Read More...
Aug 15, 2012 - Get the Latest Neurology News!: Thanks to the American Academy of Neurology (AAN), obtaining the latest information on neurological conditions is a cinch. AAN’s magazine Neurology Now is available at www.NeurologyNow.com and offe Read More...
Dec 18, 2011 - HNF to fund promising research on Charcot-Marie-Tooth: Planning, shopping, wrapping, baking--December can be so exhausting. In the middle of all the holiday activity, HNF would like to stop and shout a huge “thank you” to our supporters! Please read the l Read More...

Too often, important scientific discoveries never enter the pharmaceutical research phase due to lack of guidance, interest, or incentive. At HNF, we are not only committed to funding cutting-edge basic science research, we are also committed to seeing that our research is continued by pharmaceutical companies with the goal of producing a drug that can cure or treat CMT. In order to ensure that our research is continued on the pharmaceutical level, HNF is already working with pharmaceutical consultants to ensure that our research is being completed to industry standard. We have also structured our strategy to ensure that there is sufficient scientific and financial interest on the part of the pharmaceutical companies.

HNF is particularly grateful to Dr. Jay Tung, a Member of HNF’s Medical Advisory Board and the Vice-President of Drug Discovery at the Myelin Repair Foundation, for his guidance and expertise. HNF is impressed with the Myelin Repair Foundation’s innovative approach to research and their mechanism for driving research forward in the area of Multiple Sclerosis.

Charcot Marie Tooth (CMT)

The Foundation to support those living with CMT